CD8A and neoplasm: When active, this axis can be considered a myeloid (or innate) immune checkpoint regulator since it blocks the generation of adaptive T-cell immune responses by inducing tolerogenic signals in DCs, disturbing the priming and clonal expansion of anti-tumour CD8 + T cells.